/PRNewswire/ A latest research report [115+] pages with 360-Degree visibility, titled "Artificial Intelligence in Precision Medicine Market Share, Size,.
AI-based drug discovery with Atomwise and WEKA Data Platform hpcwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hpcwire.com Daily Mail and Mail on Sunday newspapers.
Published: Dec 21, 2020
Dec. 21, 2020 21:37 UTC
Atomwise unveils a growing portfolio of emerging joint venture companies, with programs spanning oncology, immunology, infectious disease, neuroscience and clotting disorders.
Atomwise CEO and joint venture companies are scheduled to speak at Informa s Biotech Showcase from January 11-15, 2021 during J.P. Morgan Healthcare Week.
Atomwise, the leader in using artificial intelligence (AI) for small-molecule drug discovery, today unveiled its growing portfolio of emerging joint venture companies with research programs spanning oncology, immunology, infectious disease, neuroscience and clotting disorders.
In the area of infectious disease, the company is announcing the addition of vAirus, a newly formed joint venture company with world RNA-virus expert Nito Panganiban. The joint venture will use AI-based screening to find small molecule compounds to act as novel broad-spectrum antivirals against flaviviruses, a genus of RNA-viruse
Atomwise Announces Growing Portfolio of Joint Venture Companies – IT Business Net itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.